Image

Global Breast Biopsy Devices Market – Industry Trends and Forecast to 2029

Healthcare

Image

Global Breast Biopsy Devices Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Breast Biopsy Devices Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 2.33 USD Billion
Diagram Market Size (Forecast Year) USD 4.01 USD Billion
Diagram CAGR %

Major Markets Players

  • Various companies
  • luding Scion Medical Technologies LLC
  • STERYLAB S.r.l.
  • ARGON MEDICAL
  • Danaher

Global Breast Biopsy Devices Market, By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other) – Industry Trends and Forecast to 2029.

Breast Biopsy Devices Market

Market Analysis and Size

Biopsy refers to a procedure that is used for surgical removal of tissue from an organ. The procedure is done to determine the presence or extent of a disease, including inflammatory and cancerous conditions. The prevalence of chronic diseases is escalating the growth of breast biopsy devices market.

  • Biopsies can be performed on any organ with the use of specific biopsy devices as a confirmatory test for celiac diseases and cancer. Global Breast Biopsy Devices Market was valued at USD 2.33 billion in 2021 and is expected to reach USD 4.01 billion by 2029, registering a CAGR of 7.45% during the forecast period of 2022-2029.

Market Definition

Biopsy devices refer to the devices that are utilized for removing a piece of a sample or a tissue of cells from the body in order to analyse in the laboratory for presence of a disease. The devices are used among radiologists, interventional cardiologists and surgeons. The use of these biopsy devices varies depending on the type of organ under consideration.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Forecast Period

2022 - 2029

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Scion Medical Technologies LLC (US), STERYLAB S.r.l. (Italy), ARGON MEDICAL (US), Danaher (US), Cianna Medical (US), Benetec (Belgium), Cigna (US), United Medical Systems Inc. (US), Stryker (US), BD (US), Hologic Inc. (US), Devicor Medical Products Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), OncoCyte Corporation (US), Cook (US), Siemens (Germany), Medtronic (Ireland), SOMATEX Medical Technologies GmbH (Germany), Vigeosrl (Italy), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Olympus Corporation (Japan), FUJIFILM Holdings Corporation (Japan), GENERAL ELECTRIC (US), Cardinal Health (US) and B. Braun Melsungen AG (Germany), among others

Breast Biopsy Devices Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

  • Prevalence of Cancer

The increase in the prevalence of cancer across the globe acts as one of the major factors driving the growth of breast biopsy devices market.

  • Preference for Minimally Invasive Surgeries

The increase in the inclination towards minimally invasive surgeries among population owing to the quick recovery and less pain accelerate the market growth.

  • Funds and Grants

The surge in investments in the form of funds and grants for biomarker research further influence the market growth.

Opportunities

Furthermore, development of fully integrated biopsy devices extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, emergence of liquid biopsy will assist in the expansion of the market.

Restraints/Challenges

On the other hand, concerns regarding the product recalls are expected to obstruct market growth. Also, risk of infections is projected to challenge the breast biopsy devices market in the forecast period of 2022-2029.

This breast biopsy devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on breast biopsy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Breast Biopsy Devices Market

Covid-19 had a positive impact on the breast biopsy devices market. The medical services such as biopsies witnessed decline in revenues in the years 2020 and 2021 due to the outbreak of COVID-19. Major medical procedures were declined during the pandemic in order to prevent the risk of spreading coronavirus. However, rise in the number of biopsies is expected in the post-COVID owing to the easing of restrictions.

Recent Development

  • IZI Medical Products, LLC ("IZI") launched The Quick-Core Auto Biopsy System ("Quick-Core Auto") in March’2021 for the purpose of soft tissue biopsy. Quick-Core Auto is known to be a lightweight, completely automatic biopsy equipment offering precision, reliability, and quality of IZI's Quick-Core semi-automatic biopsy system.

Global Breast Biopsy Devices Market Scope and Market Size

The biomarkers market is segmented on the basis of product, technique type, guidance technology and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Biopsy Needles
  • Biopsy Tables
  • Biopsy Wires
  • Guidance Systems
  • Others

On the basis of product, the breast biopsy devices market is segmented into biopsy needles, biopsy tables, biopsy wires, guidance systems and others.

Technique Type

  • Fine Needle Aspiration Biopsy
  • Core Needle Biopsy
  • Biopsy Markers
  • Mri-Guided Core Needle Biopsy
  • Surgical Biopsy
  • Wire Localization
  • Sentinel Node Biopsy

On the basis of technique type, the breast biopsy devices market is segmented into fine needle aspiration biopsy, core needle biopsy, biopsy markers, MRI-guided core needle biopsy, surgical biopsy, wire localization, and sentinel node biopsy.

Guidance Technology

  • Fine Ultrasound-Guided
  • Mammography-Guided Magnetic Resonance
  • Ct-Guided Biopsy
  • Other Image-Guided Breast Biopsy

On the basis of guidance technology, the breast biopsy devices market is segmented into fine ultrasound-guided, mammography-guided magnetic resonance, CT-guided biopsy, and other image-guided breast biopsy.

End User

  • Into Hospitals
  • Ambulatory Surgical Centres
  • Diagnostic Centres
  • Other

On the basis of end user, the breast biopsy devices market is segmented into hospitals, ambulatory surgical centres, and diagnostic centres and other.

Breast Biopsy Devices Market Regional Analysis/Insights

The breast biopsy devices market is analysed and market size insights and trends are provided by country, product, technique type, guidance technology and end user as referenced above.

The countries covered in the breast biopsy devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the breast biopsy devices market because of the large availability of trained medical professionals and availability of well-developed infrastructure facilities within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the surge in disposable income and rise in patient awareness toward disease screening in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The breast biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for breast biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the breast biopsy devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Breast Biopsy Devices Market Share Analysis

The breast biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to breast biopsy devices market.

Some of the major players operating in the breast biopsy devices market are Scion Medical Technologies LLC (US), STERYLAB S.r.l. (Italy), ARGON MEDICAL (US), Danaher (US), Cianna Medical (US), Benetec (Belgium), Cigna (US), United Medical Systems Inc. (US), Stryker (US), BD (US), Hologic Inc. (US), Devicor Medical Products Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), OncoCyte Corporation (US), Cook (US), Siemens (Germany), Medtronic (Ireland), SOMATEX Medical Technologies GmbH (Germany), Vigeosrl (Italy), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Olympus Corporation (Japan), FUJIFILM Holdings Corporation (Japan), GENERAL ELECTRIC (US), Cardinal Health (US) and B. Braun Melsungen AG (Germany), among others.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The breast biopsy devices market size will be worth USD 4.01 billion by 2029.
The growth rate of the breast biopsy devices market is 7.45%.
Prevalence of Cancer, Preference for Minimally Invasive Surgeries & The surge in investments in the form of funds and grants for biomarker research are the growth drivers of the breast biopsy devices market.
Major companies in the breast biopsy devices market are Scion Medical Technologies LLC (US), STERYLAB S.r.l. (Italy), ARGON MEDICAL (US), Danaher (US), Cianna Medical (US), Benetec (Belgium), Cigna (US), United Medical Systems Inc. (US), Stryker (US), BD (US), among others.
Product, technique type, guidance technology and end user are the factors on which the breast biopsy devices market research is based.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials